Stay updated on Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    UI updates include the ability to show or hide the glossary and new metadata labels: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Some terms such as 'Rheumatoid arthritis' and 'MedlinePlus Genetics' were removed or adjusted in the page content.
    Difference
    0.2%
    Check dated 2026-01-23T06:13:55.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Added related topic links for Rheumatoid arthritis and MedlinePlus Genetics; updated the page revision from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-16T04:51:35.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Rheumatoid arthritis appears to have been removed as a core topic on the page. The MedlinePlus Genetics related topics section is also removed.
    Difference
    0.1%
    Check dated 2026-01-09T03:56:50.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added related topics Rheumatoid arthritis and MedlinePlus Genetics to the page. These additions provide background information but do not affect the study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-01T23:48:56.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Expanded Locations section now lists numerous study sites across the United States and internationally, including the Revision: v3.3.3.
    Difference
    2%
    Check dated 2025-12-24T16:33:50.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Rheumatoid arthritis is added as a primary condition on the page, and a related topics section now includes MedlinePlus Genetics. These changes provide direct context for the study and link to additional resource information.
    Difference
    0.1%
    Check dated 2025-12-02T17:41:36.000Z thumbnail image

Stay in the know with updates to Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.